About us
Overview
Our strategy
Our leadership
How we’re funded
Our history
What we do
Overview
Our science
Therapeutics
Diagnostics development
Partnering with us
Funding, projects and partnerships
Available technologies
LifeArc Ventures
IP management and tech transfer
Policy and public affairs
Translational Challenges
Overview
Motor Neuron Disease
Chronic Respiratory Infection
Global Health
Antimicrobial Resistance
Neglected Tropical Diseases
Emerging Viral Threats
Rare Disease
Childhood Cancer
News and events
News
Events
Careers
Overview
Benefits and rewards
Early careers
Current vacancies
Contact us
Search
Toggle Menu
News
News
Events
Filter
Topics
Company updates
Motor neuron disease
Chronic respiratory infection
Global health
Antimicrobial resistance
Emerging viral threats
Neglected tropical diseases
Rare disease
Childhood cancer
Neurodegeneration
Policy and public affairs
Technology transfer
Our science
Drug discovery
Antibody humanisation
Ventures
26 October 2005
MRC to receive over USD200m
Read more
: MRC to receive over USD200m
Previous page
1
…
31
32
33
Want the latest news from us?
Sign up for updates
Contact our media team
Close Modal